Log in
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Dynamic quotes 
  1. Homepage
  2. Equities
  3. Canada
  4. Toronto Stock Exchange
  5. Burcon NutraScience Corporation
  6. News
  7. Summary
    BU   CA1208311029


SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

PRESS RELEASE: Burcon JV Company, Merit Functional Foods, Achieves First Commercial Production of Canola Protein

04/12/2021 | 01:01pm EDT
DGAP-News: Burcon NutraScience Corp. / Key word(s): Product Launch 
Burcon JV Company, Merit Functional Foods, Achieves First Commercial Production of Canola Protein 
2021-04-12 / 19:00 
The issuer is solely responsible for the content of this announcement. 
Burcon JV Company, Merit Functional Foods, Achieves First Commercial Production of Canola Protein 
A Global Plant-based Protein First For Canola 
Vancouver, British Columbia, April 12, 2021 - Burcon NutraScience Corporation (TSX: BU) (OTCQB: BUROF), a global 
technology leader in the development of clean-label, plant-based proteins for foods and beverages, is pleased to 
announce that its joint venture company, Merit Functional Foods Corporation ("Merit Foods" or "Merit"), has achieved 
first commercial production of its novel lineup of Puratein(R) canola proteins. Merit's new, state-of-the-art, 
plant-based protein production complex is now the first and only commercial-scale facility in the world capable of 
producing food-grade protein from canola, the world's second-largest oilseed crop. Merit intends to continue optimizing 
the manufacturing process in the coming weeks, with an expectation of fulfilling commercial commitments in Q2 for its 
better-tasting, better-functioning and better-for-you plant proteins. 
"This is a truly momentous achievement for us and one that has been a long time in the making," said Johann F. 
Tergesen, Burcon's president and chief executive officer, adding: "Burcon first embraced the vision of canola's 
potential as a premium, food-grade protein source over 20 years ago. Today, Merit Foods, with its just-completed 
high-tech plant protein production facility, is bringing eco-friendly canola proteins to market using Burcon's patented 
processing technology. These proteins stand to change the way the world's consumers get their protein." 
"This milestone is a significant step toward fulfilling canola's enormous global potential as an important, new, 
environmentally friendly source of high-quality, plant-based protein for food and beverage product development. As the 
world's second-largest oilseed crop, canola protein is perfectly positioned to offer a sustainable way to feed and 
nourish the world's growing population." 
Canola was originally developed out of rapeseed in the 1970s after many years' efforts by Canadian researchers Baldur 
Stefansson and Keith Downey, considered the fathers of canola. This scientific advance enabled the production and use 
of canola oil for human consumption. Since that time, canola agricultural production has expanded globally to now be 
the number two oilseed in the world-behind soybeans and ahead of sunflower seed, peanuts and cottonseed. Burcon's 
world-leading team of food scientists and chemical engineers has worked for more than two decades to unlock the full 
nutritional and functional properties of canola proteins. Burcon's efforts have culminated in the opening of Merit's 
new plant protein processing facility, and now the commercial-scale production of Merit's novel lineup of Puratein(R) 
canola proteins. 
Merit's new, ultramodern, plant-based protein production facility is dedicated to the production, of novel pea and 
canola protein ingredients using licensed technology from Burcon. Unique in its design and structured for rapid 
expansion, Merit's 94,000-square-foot facility has been engineered and constructed to be able to process both non-GMO 
canola and yellow field peas, giving it the ability to produce Merit's lineup of Puratein(R) canola proteins, its 
Peazazz(R)and Peazac(R) pea proteins, and its MeritPro(TM) protein blends. Merit's Puratein(R), Peazazz(R), Peazac(R) 
and MeritPro(TM) are ideal ways for food and beverage companies to give their products a much-needed nutritional boost 
while remaining dairy-free, soy-free, grain-free and gluten-free. 
Broadcast-quality Burcon and canola video footage can be downloaded here. 
About Burcon NutraScience Corporation 
Burcon is a global technology leader in the development of clean-label, plant-based proteins for foods and beverages. 
With over 300 issued patents and more than 225 additional patent applications developed over a span of more than 20 
years, Burcon has grown an extensive portfolio of composition, application and process patents covering novel 
plant-based proteins derived from pea, canola, soy, hemp, sunflower seed and more. In 2019, Merit Functional Foods 
Corporation was established in a joint venture between Burcon and three veteran food industry executives. Merit Foods 
has built a state-of-the-art protein production facility in Manitoba, Canada to produce, under licence, Burcon's novel 
pea and canola protein ingredients. For more information, visit www.burcon.ca. 
Forward-Looking Information Cautionary Statement 
The TSX has not reviewed and does not accept responsibility for the adequacy of the content of the information 
contained herein. This press release contains forward-looking statements or forward-looking information within the 
meaning of the U.S. Private Securities Litigation Reform Act of 1995 and applicable Canadian securities legislation. 
Forward-looking statements or forward-looking information involve risks, uncertainties and other factors that could 
cause actual results, performances, prospects and opportunities to differ materially from those expressed or implied by 
such forward-looking statements. Forward-looking statements or forward-looking information can be identified by words 
such as "anticipate," "intend," "plan," "goal," "project," "estimate," "expect," "believe," "future," "likely," "may," 
"should," "could," "will" and similar references to future periods. All statements included in this release, other than 
statements of historical fact, are forward-looking statements, including, without limitation, statements regarding the 
expected use of proceeds contained in this press release. There can be no assurance that such statements will prove to 
be accurate, and actual results and future events could differ materially from those anticipated in such statements or 
information. Important factors that could cause actual results to differ materially from Burcon's plans and 
expectations include the actual results of business negotiations; marketing activities; adverse general economic, 
market or business conditions; regulatory changes; and other risks and factors detailed herein and from time to time in 
the filings made by Burcon with securities regulators and stock exchanges, including in the section entitled "Risk 
Factors" in Burcon's annual information form dated June 29, 2020 filed with the Canadian securities administrators on 
www.sedar.com. Any forward-looking statement or information speaks only as of the date on which it was made, and, 
except as may be required by applicable securities laws, Burcon disclaims any intent or obligation to update any 
forward-looking statement, whether as a result of new information, future events or otherwise. Although Burcon believes 
the assumptions inherent in the forward-looking statements are reasonable, forward-looking statements are not 
guarantees of future performance, and, accordingly, investors should not rely on such statements. 
Industry Contact 
Paul Lam 
Manager, Business Development and IRO 
Burcon NutraScience Corporation 
Tel (604) 733-0896, Toll-free (888) 408-7960 
plam@burcon.ca www.burcon.ca 
Investor Contact 
James Carbonara 
Hayden IR 
Tel (646) 755-7412 
Media Contact: 
Steve Campbell, APR 
Campbell & Company Public Relations 
Tel (604) 888-5267 
2021-04-12 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG. 
The issuer is solely responsible for the content of this announcement. 
The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. 
Archive at www.dgap.de 

1183776 2021-04-12

(END) Dow Jones Newswires

April 12, 2021 13:00 ET (17:00 GMT)

Stocks mentioned in the article
ChangeLast1st jan.
BURCON NUTRASCIENCE CORPORATION 2.26% 4.07 Delayed Quote.18.31%
DJ INDUSTRIAL 1.06% 34382.13 Delayed Quote.11.16%
LONDON BRENT OIL 2.73% 68.82 Delayed Quote.29.59%
MOMENTOUS HOLDINGS CORP. 0.00% 0.12 Delayed Quote.9.09%
S&P/TSX COMPOSITE INDEX 1.21% 19366.69 Delayed Quote.11.09%
SOYBEAN MEAL FUTURES (ZM) - CBE (ELECTRONIC)/C1 -6.08% 423.5 End-of-day quote.-2.51%
WTI 2.59% 65.462 Delayed Quote.32.44%
YRC WORLDWIDE INC. 3.59% 6.34 Delayed Quote.43.12%
04/12PRESS RELEASE : Burcon JV Company, Merit Functional Foods, Achieves First Commer..
04/12BURCON NUTRASCIENCEá : JV Company, Merit Functional Foods, Achieves First Commer..
04/12Burcon JV Company, Merit Functional Foods, Achieves First Commercial Producti..
03/05PRESS RELEASEá : Burcon to Participate in the 33rd Annual ROTH Conference on Mar..
03/05BURCON NUTRASCIENCEá : to Participate in the 33rd Annual ROTH Conference on Marc..
03/04Burcon to Participate in the 33rd Annual ROTH Conference on March 15-17, 2021
02/17PRESS RELEASEá : Burcon NutraScience Corp.: Burcon -2-
02/17PRESS RELEASE : Burcon NutraScience Corp.: Burcon Reports Fiscal 2021 Third Quar..
02/17BURCON NUTRASCIENCE CORP. : Burcon Reports Fiscal 2021 Third Quarter Results
02/16Burcon Reports Fiscal 2021 Third Quarter Results
More news
Sales 2021 0,10 M 0,08 M 0,08 M
Net income 2021 -0,22 M -0,18 M -0,18 M
Net cash 2021 10,1 M 8,33 M 8,33 M
P/E ratio 2021 -
Yield 2021 -
Capitalization 441 M 365 M 364 M
EV / Sales 2021 4 313x
EV / Sales 2022 110x
Nbr of Employees 21
Free-Float 75,8%
Duration : Period :
Burcon NutraScience Corporation Technical Analysis Chart | MarketScreener
Full-screen chart
Short TermMid-TermLong Term
Income Statement Evolution
Mean consensus BUY
Number of Analysts 3
Average target price 6,83 CAD
Last Close Price 4,07 CAD
Spread / Highest target 96,6%
Spread / Average Target 67,9%
Spread / Lowest Target 47,4%
EPS Revisions
Managers and Directors
Johann Franz Tergesen President & Chief Executive Officer
Jade Cheng Chief Financial Officer
David Lorne John Tyrrell Chairman
Martin Hans Schweizer Vice President-Technical Development
John Douglas Gilpin Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
BY-HEALTH CO., LTD.38.51%8 216
MEDIFAST, INC.45.86%3 477